Rein Therapeutics, Inc. (RNTX) Dividend History

Rein Therapeutics, Inc. (RNTX) is a biopharmaceutical company focused on developing therapies targeting neurodegenerative diseases. The company's research emphasizes innovative approaches to treat conditions such as Parkinson’s disease and other neurodegenerative disorders, leveraging advances in molecular biology and drug delivery technologies.